NYSE: ABBV
AbbVie Inc.
Healthcare · Drug Manufacturers - General
After hours: $259.46(+0.21%) · as of 7:59 PM ET
Market Cap
$457.46B
52w High
$267.47
52w Low
$190.75
P/E
72.62
Volume
3.76M
Outstanding Shares
1.77B
Performance
Return analysis
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 21.18% over the last year. Revenue grew 10.39% over the trailing twelve months. Operating margin moved from 18.8% to 29.32%. Free cash flow grew 7.91% over the trailing twelve months.
What the market seems to be pricing
The stock is trading toward the richer end of its historical P/FCF range (98th percentile) while business metrics are improving. More of the upside is already embedded in the multiple now.
What would invalidate this read
Operating margin is at 29.32% — continued expansion would be needed to justify the premium. Revenue growth of 10.39% is encouraging, but any deceleration puts the stretched multiple at risk. This read changes if revenue, margins, and cash flow continue to improve faster than expected — in that case the richer multiple could still prove conservative.
Company profile
AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
30
Buy
11
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Oct 30, 2026
Q4 FY26 · EPS est $3.87 · Revenue est $17.31B
View
Dividends
$6.83/shareQuarterlyDividend Achiever · 12yrAt RiskABBV pays a dividend with a 2.64% dividend yield, 12 consecutive years of growth, growing at 6.1% annually, covered 1.5× by free cash flow.
Dividend Yield
2.64%
Annual Div / Share
$6.83
5yr CAGR
+6.1%
Doubles every ~11.7yr
Payout Ratio
189.71%
At Risk
Dividend Growth Rate
3yr CAGR
+5.3%
5yr CAGR
+6.1%
10yr CAGR
+11.89%
Dividend History
Annualized dividend cycles per share
Income Projection
Today
$2/mo
In 5 yrs
$3/mo
In 10 yrs
$4/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$26/yr $2/mo | $35/yr+34% $3/mo | $48/yr+81% $4/mo |
Yield-on-cost grows from 2.64% → 4.77% over 10yr
Analysis
Dividend Strengths
Dividend Achiever
ABBV has raised its dividend for 12 consecutive years — qualifying as a Dividend Achiever, demonstrating long-term commitment to shareholder income.
Well-covered by free cash flow
The dividend is covered 1.5× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Strong dividend growth rate
The 5-year CAGR of 6.1% meaningfully outpaces inflation, compounding real income growth for long-term holders.
Risks to Watch
High payout ratio
With 189.71% of earnings paid as dividends, there is limited retained earnings for reinvestment — and a dividend cut becomes more likely if earnings decline.